Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David P Richman

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Neurology|December 25, 2003
Treatment of autoimmune myasthenia gravisDavid P Richman, Mark A Agius
Annals of the New York Academy of Sciences|November 1, 2003
Treatment principles in the management of autoimmune myasthenia gravisDavid P Richman, Mark A Agius
Biochimica Et Biophysica Acta|December 9, 2014
Myasthenia gravis and related disorders: Pathology and molecular pathogenesisJames C Ha, David P Richman
Frontiers in Immunology|May 28, 2020
Muscle-Specific Kinase Myasthenia GravisLucia S Borges, David P Richman
Journal of Clinical Neurology (Seoul, Korea)|January 20, 2012
Treatment of myasthenia gravis based on its immunopathogenesisJee Young Kim, Kee Duk Park, David P Richman
Neurology|February 7, 2016
Myasthenia gravis exacerbation after discontinuing mycophenolate: A single-center cohort studyBjörn Oskarsson, David M Rocke, Karsten Dengel, et al.
Experimental Neurology|January 17, 2015
How clinical trials of myasthenia gravis can inform pre-clinical drug developmentAnna Rostedt Punga, Henry J Kaminski, David P Richman, et al.
Journal of the Neurological Sciences|May 3, 2011
Accelerated central nervous system autoimmunity in BAFF-receptor-deficient miceSusan S Kim, David P Richman, Scott S Zamvil, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|April 19, 2017
Acute Stroke Despite Dabigatran Anticoagulation Treated with Idarucizumab and Intravenous Tissue Plasminogen ActivatorDavid Bissig, Rashmi Manjunath, Brittany R Traylor, et al.
Cognitive and Behavioral Neurology : Official Journal of the Society for Behavioral and Cognitive Neurology|April 7, 2011
Cerebral venous sinus thrombosis presenting with auditory hallucinations and illusionsVictoria S S Wong, Peter Adamczyk, Brian Dahlin, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Neurology|December 25, 2003
Treatment of autoimmune myasthenia gravisDavid P Richman, Mark A Agius
Annals of the New York Academy of Sciences|November 1, 2003
Treatment principles in the management of autoimmune myasthenia gravisDavid P Richman, Mark A Agius
Biochimica Et Biophysica Acta|December 9, 2014
Myasthenia gravis and related disorders: Pathology and molecular pathogenesisJames C Ha, David P Richman
Frontiers in Immunology|May 28, 2020
Muscle-Specific Kinase Myasthenia GravisLucia S Borges, David P Richman
Journal of Clinical Neurology (Seoul, Korea)|January 20, 2012
Treatment of myasthenia gravis based on its immunopathogenesisJee Young Kim, Kee Duk Park, David P Richman
Neurology|February 7, 2016
Myasthenia gravis exacerbation after discontinuing mycophenolate: A single-center cohort studyBjörn Oskarsson, David M Rocke, Karsten Dengel, et al.
Experimental Neurology|January 17, 2015
How clinical trials of myasthenia gravis can inform pre-clinical drug developmentAnna Rostedt Punga, Henry J Kaminski, David P Richman, et al.
Journal of the Neurological Sciences|May 3, 2011
Accelerated central nervous system autoimmunity in BAFF-receptor-deficient miceSusan S Kim, David P Richman, Scott S Zamvil, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|April 19, 2017
Acute Stroke Despite Dabigatran Anticoagulation Treated with Idarucizumab and Intravenous Tissue Plasminogen ActivatorDavid Bissig, Rashmi Manjunath, Brittany R Traylor, et al.
Cognitive and Behavioral Neurology : Official Journal of the Society for Behavioral and Cognitive Neurology|April 7, 2011
Cerebral venous sinus thrombosis presenting with auditory hallucinations and illusionsVictoria S S Wong, Peter Adamczyk, Brian Dahlin, et al.
Pageof 3